Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial

Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record now presents details of Sanofi’s completed Phase 3 tolebrutinib study for relapsing multiple sclerosis, including its design, outcomes, eligibility criteria, and study locations. It also includes results-related publications and study documents; the trial is no longer recruiting.
    Difference
    100%
    Check dated 2026-11-08T14:05:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:30:24.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:20:46.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:01:30.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:52:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, indicating an access restriction. This suggests a server-side issue or blocked access to the study record page.
    Difference
    17%
    Check dated 2026-09-20T20:26:12.000Z thumbnail image

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.